310. 先天異常症候群 Congenital anomalies syndrome Clinical trials / Disease details

臨床試験数 : 11 / 薬物数 : 20 - (DrugBank : 10) / 標的遺伝子数 : 3 - 標的パスウェイ数 : 7

1 trial found

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00064792 (ClinicalTrials.gov)	July 2003	11/7/2003	Simvastatin Therapy in Smith-Lemli-Opitz Syndrome	Investigation of Simvastatin Therapy in Smith-Lemli-Opitz Syndrome	Smith-Lemli-Opitz Syndrome	Drug: Simvastatin Susp.;Drug: OraPlus	Forbes Porter, M.D.	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)	Completed	4 Years	18 Years	All	23	Phase 2	United States

First Previous1Next Last